Tumor promoting effect of PDLIM2 downregulation involves mitochondrial ROS, oncometabolite accumulations and HIF-1α activation

Jingxing Yang(National Health Research Institutes), Tsung‐Hsien Chuang(National Health Research Institutes)
Journal of Experimental & Clinical Cancer Research
June 17, 2024
Cited by 15


Related Papers